Lanx hauls in $15M for spinal devices

Colorado's Lanx has wrapped up a $15 million Series C, money the devicemaker will use to market its spinal fusion technologies around the globe. Lanx pulled in about $8.7 million of the total as of October, closing the difference in the ensuing months thanks to investors including Chicago Growth Partners and Goldman Sachs Private Equity Opportunities Fund. Now, Lanx plans to boost its sales infrastructure and expand the use of its Timberline Lateral Fusion System and Aspen MIS Fusion System. More

Suggested Articles

The former Fierce 15 winner’s SuperMap program was cleared to guide electrophysiologists in the treatment of stable and transient arrhythmias.

Insulet announced new agreements with Abbott and Dexcom to connect their continuous glucose monitors with its upcoming tubeless, digital insulin pump,

In an SEC filing, Baxter International disclosed that it may have overstated its income over multiple years, inflating it by about $276 million.